ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,852, issued on June 2, was assigned to Vincere Biosciences Inc. (Cambridge, Mass.).

"USP30 inhibitors and uses thereof" was invented by Donna L. Romero (Chesterfield, Mo.), Michael Garrett Johnson (San Francisco), Andrew David Lee (Jacksonville, Fla.), Bahareh Behrouz (Jacksonville, Fla.) and Edward Lawrence Fritzen Jr. (Niantic, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of USP30, and the treatment of USP30-mediated disorders."

The patent was filed on Nov. 9, 2023, under Application No. 18/505,719.

*For further information, in...